Ingrid Catz
About
Ingrid Catz is a scholar working on Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Molecular Biology.
According to data from OpenAlex, Ingrid Catz has authored 37 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pathology and Forensic Medicine, 15 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Molecular Biology. Recurrent topics in Ingrid Catz's work include Multiple Sclerosis Research Studies (24 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Peripheral Neuropathies and Disorders (7 papers). Ingrid Catz is often cited by papers focused on Multiple Sclerosis Research Studies (24 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Peripheral Neuropathies and Disorders (7 papers). Ingrid Catz collaborates with scholars based in Canada, United States and India. Ingrid Catz's co-authors include Kenneth G. Warren, Lawrence Steinman, Kai W. Wucherpfennig, Edward S. Johnson, William H. Robinson, Jennifer L. Kanter, Peggy P. Ho, Raymond A. Sobel, Mark J. Krantz and Stefan Hausmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.
In The Last Decade
Ingrid Catz
37 papers receiving 1.7k citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ingrid Catz Canada | 21 | 862 | 715 | 550 | 489 | 353 | 37 | 1.8k | ||
| John N. Whitaker United States | 17 | 696 0.8× | 418 0.6× | 514 0.9× | 213 0.4× | 410 1.2× | 44 | 1.7k | ||
| J. Paul Banga United Kingdom | 33 | 633 0.7× | 789 1.1× | 812 1.5× | 505 1.0× | 234 0.7× | 128 | 3.3k | ||
| M W Kies United States | 15 | 331 0.4× | 635 0.9× | 661 1.2× | 191 0.4× | 149 0.4× | 30 | 1.6k | ||
| Diego Franciotta Italy | 15 | 844 1.0× | 509 0.7× | 316 0.6× | 65 0.1× | 368 1.0× | 20 | 1.8k | ||
| Gary J. Williams United States | 19 | 517 0.6× | 499 0.7× | 441 0.8× | 54 0.1× | 152 0.4× | 29 | 1.6k | ||
| Volker Siffrin Germany | 22 | 586 0.7× | 717 1.0× | 434 0.8× | 84 0.2× | 152 0.4× | 50 | 1.8k | ||
| N Patronas United States | 20 | 411 0.5× | 127 0.2× | 311 0.6× | 565 1.2× | 743 2.1× | 27 | 2.5k | ||
| Tatiana Plavina United States | 22 | 1.4k 1.7× | 480 0.7× | 350 0.6× | 113 0.2× | 444 1.3× | 46 | 2.6k | ||
| Catherine Agoropoulou Switzerland | 5 | 1.6k 1.8× | 352 0.5× | 942 1.7× | 47 0.1× | 536 1.5× | 7 | 2.2k | ||
| Ana de Vera Switzerland | 11 | 1.6k 1.9× | 454 0.6× | 1.0k 1.9× | 46 0.1× | 535 1.5× | 17 | 2.3k |
Countries citing papers authored by Ingrid Catz
Since
Specialization
Citations
This map shows the geographic impact of Ingrid Catz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Catz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Catz more than expected).
Fields of papers citing papers by Ingrid Catz
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ingrid Catz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Catz. The network helps show where Ingrid Catz may publish in the future.
Co-authorship network of co-authors of Ingrid Catz
This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Catz. A scholar is included among the top collaborators of Ingrid Catz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Catz. Ingrid Catz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Giuliani, Fabrizio, Ingrid Catz, Edward S. Johnson, Lothar Resch, & Kenneth G. Warren. (2011). Loss of Purkinje Cells is Associated with Demyelination in Multiple Sclerosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 38(3). 529–531.
2.
Lebel, R. Marc, Anna Zavodni, Kenneth G. Warren, et al.. (2009). Detecting lesions in multiple sclerosis at 4.7 tesla using phase susceptibility‐weighting and T2‐weighting. Journal of Magnetic Resonance Imaging. 30(4). 737–742.
3.
Warren, Kenneth G., et al.. (2006). Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II‐defined cohort of patients with progressive multiple sclerosis: results of a 24‐month double‐blind placebo‐controlled clinical trial and 5 years of follow‐up treatment. European Journal of Neurology. 13(8). 887–895.
4.
O’Connor, Kevin C., Heiner Appel, Lisa Bregoli, et al.. (2005). Antibodies from Inflamed Central Nervous System Tissue Recognize Myelin Oligodendrocyte Glycoprotein. The Journal of Immunology. 175(3). 1974–1982.
5.
Kanter, Jennifer L., Peggy P. Ho, Ingrid Catz, et al.. (2005). Lipid microarrays identify key mediators of autoimmune brain inflammation. Nature Medicine. 12(1). 138–143.
6.
Warren, Kenneth G. & Ingrid Catz. (1999). An Extensive Search for Autoantibodies to Myelin Basic Protein in Cerebrospinal Fluid of Non-Multiple-Sclerosis Patients: Implications for the Pathogenesis of Multiple Sclerosis. European Neurology. 42(2). 95–104.
7.
Wucherpfennig, Kai W., Ingrid Catz, Stefan Hausmann, et al.. (1997). Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.. Journal of Clinical Investigation. 100(5). 1114–1122.
8.
Warren, Kenneth G. & Ingrid Catz. (1997). The effect of intrathecal MBP synthetic peptides containing epitope P85VVHFFKNIVTP96 on free anti-MBP levels in acute relapsing multiple sclerosis. Journal of the Neurological Sciences. 148(1). 67–78.
9.
Warren, Kenneth G., Ingrid Catz, & Kai W. Wucherpfennig. (1997). Tolerance induction to myelin basic protein by intravenous synthetic peptides containing epitope P85VVHFFKNIVTP96 in chronic progressive multiple sclerosis. Journal of the Neurological Sciences. 152(1). 31–38.
10.
Warren, Kenneth G. & Ingrid Catz. (1995). Administration of myelin basic protein synthetic peptides to multiple sclerosis patients. Journal of the Neurological Sciences. 133(1-2). 85–94.
11.
Warren, Kenneth G., Ingrid Catz, Edward S. Johnson, & Bruce W. Mielke. (1994). Anti‐myelin basic protein and anti‐proteolipid protein specific forms of multiple sclerosis. Annals of Neurology. 35(3). 280–289.
12.
Warren, Kenneth G. & Ingrid Catz. (1993). Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue. Journal of the Neurological Sciences. 115(2). 169–176.
13.
Warren, Kenneth G. & Ingrid Catz. (1993). Increased synthetic peptide specificity of tissue-CSF bound anti-MBP in multiple sclerosis. Journal of Neuroimmunology. 43(1-2). 87–96.
14.
Warren, Kenneth G. & Ingrid Catz. (1992). Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid. Journal of Neuroimmunology. 39(1-2). 81–89.
15.
Warren, Kenneth G. & Ingrid Catz. (1991). Purification of autoantibodies to myelin basic protein by antigen specific affinity chromatography from cerebrospinal fluid IgG of multiple sclerosis patients Immunoreactivity studies with human myelin basic protein. Journal of the Neurological Sciences. 103(1). 90–96.
16.
Warren, Kenneth G. & Ingrid Catz. (1990). A myelin basic protein antibody cascade in purified IgG from cerebrospinal fluid of multiple sclerosis patients. Journal of the Neurological Sciences. 96(1). 19–27.
17.
Warren, Kenneth G. & Ingrid Catz. (1989). Cerebrospinal fluid autoantibodies to myelin basic protein in multiple sclerosis patients. Journal of the Neurological Sciences. 91(1-2). 143–151.
18.
Warren, Kenneth G. & Ingrid Catz. (1988). Neutralization of anti-myelin basic protein by cerebrospinal fluid of multiple sclerosis patients in clinical remission. Journal of the Neurological Sciences. 88(1-3). 185–194.
19.
Warren, Kenneth G., et al.. (1987). Effects of High-to-Mega-Dose Synthetic Corticosteroids on Multiple Sclerosis Patients with Special Reference to Cerebrospinal Fluid Antibodies to Myelin Basic Protein. Clinical Neuropharmacology. 10(5). 397–411.
20.
Warren, Kenneth G. & Ingrid Catz. (1985). The relationship between levels of cerebrospinal fluid myelin basis protein and IgG measurements in patients with multiple sclerosis. Annals of Neurology. 17(5). 475–480.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by John N. Whitaker Breakdown of academic impact, for papers by J. Paul Banga Breakdown of academic impact, for papers by M W Kies Breakdown of academic impact, for papers by Diego Franciotta Breakdown of academic impact, for papers by Gary J. Williams Breakdown of academic impact, for papers by Volker Siffrin Breakdown of academic impact, for papers by N Patronas Breakdown of academic impact, for papers by Tatiana Plavina Breakdown of academic impact, for papers by Catherine Agoropoulou Breakdown of academic impact, for papers by Ana de Vera